✦ LIBER ✦

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma

✍ Scribed by Kruit, WHJ; Punt, CJA; Goey, SH; de Mulder, PHM; Gratama, JW; Eggermont, AMM; Bolhuis, RLH; Stoter, G

Book ID: 109837290
Publisher: Nature Publishing Group
Year: 1996
Tongue: English
Weight: 763 KB
Volume: 74
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1996.463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Daily alternating administration of high

Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study

✍ Lothar Bergmann; Klaus Fenchel; Eckhart Weidmann; Hans-Martin Enzinger; Bernhard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 852 KB

Trends in the safety of high dose bolus

Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer

✍ Udai S. Kammula; Donald E. White; Steven A. Rosenberg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## BACKGROUND. Administration of recombinant high dose interleukin-2 (IL-2) can mediate tumor regression in patients with metastatic melanoma and renal carcinoma. Significant trends in the safety of high dose IL-2 administration at a single institution over a 12-year study period were reviewed. #

Clinical results of two different dose r

Clinical results of two different dose regimens with high-dose interferon-alpha and interleukin-2 in advanced renal cell cancer and malignant melanoma

✍ K. Fenchel; A. Winkler; PS. Mitrou; D. Hoelzer; L. Bergmann 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 112 KB

A phase II study of dacarbazine, cisplat

A phase II study of dacarbazine, cisplatin, interferon-α and high-dose interleukin-2 in ‘poor-risk’ metastatic melanoma

✍ T.M. Proebstle; C. Scheibenbogen; W. Sterry; U. Keilholz 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 452 KB

Comparison of acute toxicity and mortali

Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma

✍ Laura M. Alwan, Kenneth Grossmann, Daniel Sageser, Joan Van Atta… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

Toxicity and feasibility of adjuvant hig

Toxicity and feasibility of adjuvant high dose interferon alpha-2b in patients with melanoma

✍ C. Bédane; A. Ravaud; L. Geoffrois; t. Lesimple; M. Delaunay; J.M. Bonnetblanc 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB